Who owns VERVE THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Verve Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Verve Therapeutics stock

Who bought or sold VERVE THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
DekaBank Deutsche Girozentrale 24k $344k 0% Dec 2025
 View chart

Who sold out of Verve Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Pentwater Capital Management Jun 2025 6.7M $76M
Baker Bros. Advisors Jun 2025 1.7M $19M
Two Sigma Investments Jun 2025 812k $9.1M
Redmile Group Jun 2025 740k $8.3M
Citadel Advisors Jun 2025 595k $6.7M
Weiss Asset Management LP[1 Jun 2025 538k $6.0M
Two Sigma Advisers Jun 2025 381k $4.3M
Wellington Management Company Jun 2025 299k $3.4M
CNH Partners Jun 2025 209k $2.3M
Balyasny Asset Management Jun 2025 173k $1.9M
AQR Capital Management Jun 2025 172k $1.9M
Millennium Management Jun 2025 138k $1.6M
XTX Topco Sep 2025 125k $0
Alliancebernstein Jun 2025 68k $765k
Greenland Capital Management Sep 2025 50k $556k
Algert Coldiron Investors Jun 2025 32k $361k
TIG Advisors Jun 2025 32k $360k
Springbok Capital Management Jun 2025 31k $345k
Harvest Management Jun 2025 30k $337k
Hsbc Holdings Jun 2025 27k $307k